Q2 Holdings, Inc. (NYSE:QTWO – Get Free Report) President Kirk L. Coleman sold 10,428 shares of the business’s stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $106.42, for a total transaction of $1,109,747.76. Following the completion of the transaction, the president now directly owns 337,643 shares of the company’s stock, valued at approximately $35,931,968.06. This represents a 3.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Q2 Price Performance
QTWO opened at $105.10 on Friday. Q2 Holdings, Inc. has a 52-week low of $39.64 and a 52-week high of $112.82. The company has a 50 day moving average of $94.62 and a two-hundred day moving average of $77.39. The company has a market cap of $6.35 billion, a P/E ratio of -109.48 and a beta of 1.60. The company has a quick ratio of 2.50, a current ratio of 2.50 and a debt-to-equity ratio of 0.99.
Analyst Ratings Changes
QTWO has been the subject of several recent analyst reports. Morgan Stanley lifted their target price on shares of Q2 from $65.00 to $90.00 and gave the stock an “equal weight” rating in a research note on Thursday, November 7th. The Goldman Sachs Group upped their target price on Q2 from $86.00 to $103.00 and gave the company a “buy” rating in a research note on Thursday, November 7th. Compass Point raised their price target on Q2 from $91.00 to $107.00 and gave the stock a “buy” rating in a research note on Thursday, November 7th. Citigroup cut Q2 from a “buy” rating to a “neutral” rating and lifted their price target for the company from $72.00 to $90.00 in a report on Friday, October 18th. Finally, DA Davidson increased their price objective on shares of Q2 from $76.00 to $86.00 and gave the stock a “neutral” rating in a report on Monday, November 11th. Five investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $91.50.
Institutional Trading of Q2
A number of institutional investors have recently added to or reduced their stakes in QTWO. CWM LLC lifted its stake in shares of Q2 by 54.2% during the second quarter. CWM LLC now owns 481 shares of the technology company’s stock worth $29,000 after purchasing an additional 169 shares in the last quarter. SG Americas Securities LLC raised its holdings in shares of Q2 by 1,371.6% during the 2nd quarter. SG Americas Securities LLC now owns 48,400 shares of the technology company’s stock valued at $2,920,000 after buying an additional 45,111 shares during the period. Raymond James & Associates lifted its position in Q2 by 2.3% during the 2nd quarter. Raymond James & Associates now owns 109,159 shares of the technology company’s stock worth $6,586,000 after acquiring an additional 2,467 shares in the last quarter. RiverPark Advisors LLC boosted its holdings in Q2 by 9.6% in the 2nd quarter. RiverPark Advisors LLC now owns 6,737 shares of the technology company’s stock worth $406,000 after acquiring an additional 591 shares during the period. Finally, Conestoga Capital Advisors LLC grew its position in Q2 by 2.5% in the second quarter. Conestoga Capital Advisors LLC now owns 2,273,894 shares of the technology company’s stock valued at $137,184,000 after acquiring an additional 54,970 shares in the last quarter.
About Q2
Q2 Holdings, Inc provides cloud-based digital solutions to regional and community financial institutions in the United States. The company offers Digital Banking Platform, an end-to-end digital banking platform supports its financial institution customers in their delivery of unified digital banking services across digital channels.
Featured Stories
- Five stocks we like better than Q2
- Transportation Stocks Investing
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- CD Calculator: Certificate of Deposit Calculator
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is a Special Dividend?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Q2 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Q2 and related companies with MarketBeat.com's FREE daily email newsletter.